A genetic mutation that carries a 90% cancer risk has been passed on by an unwitting sperm donor to dozens of children, a ...

European fertility clinics used cancer-causing sperm for 17 years, prompting urgent calls for genetic screening reforms and ...

A sperm donor with a rare genetic mutation linked to an increased risk of developing cancer fathered at least 197 children ...

A sprawling international fertility scandal is forcing regulators and doctors across Europe to rethink donor screening after ...

Because only part of the man's sperm carried the mutation, only the second round of genetic testing revealed the problem. By ...

FDA approved omidubicel (Omisirge) as the first hematopoietic stem cell transplant therapy for severe aplastic anemia. The ...

TP53 mutations are crucial in cancer development and treatment response, influenced by genetic and environmental factors. In CLL and AML, TP53 serves as a significant prognostic marker, affecting ...

Carrick Therapeutics Inc., an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced positive results from the Phase 2 SUMIT-BC clinical ...

A large international study led by researchers at Memorial Sloan Kettering has immediate clinical relevance for risk assessment and treatment of people with myelodysplastic syndrome and acute myeloid ...

p53 mutants are among the most common protein variants expressed in cancer cells. Classifying TP53 status in human cancer as ‘inactivated’ or ‘loss-of-function’ is misleading. Many mutant p53 variants ...

Nearly 200 children have been conceived using sperm from a donor with a cancer-causing gene, an investigation in Europe has revealed.